Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jul 28, 2024; 30(28): 3403-3417
Published online Jul 28, 2024. doi: 10.3748/wjg.v30.i28.3403
Table 1 Clinicopathological data of patients with rectal neuroendocrine neoplasms, n (%)

All (n = 1408)
n
Sex1408
    Female591 (42.0)
    Male817 (58.0)
Age, year51.9 (12.1)1408
Size (cm)1408
    ≤ 1872 (61.9)
    1-2291 (20.7)
    > 2171 (12.1)
    NA74 (5.3)
Size (cm)1.3 (1.2)1334
Neoadjuvant therapy1408
    No1385 (98.4)
    Yes23 (1.6)
Complete resection
    No48 (3.4)
    Yes1360 (96.6)
Pathological type1408
    NET1307 (92.8)
    NEC71 (5.0)
    MANEC14 (1.0)
    NA16 (1.1)
Pathological grade,1408
    G11149 (81.6)
    G2158 (11.2)
    G385 (6.0)
    NA16 (1.1)
T stage1408
    T11150 (81.7)
    T2140 (9.9)
    T382 (5.8)
    T436 (2.6)
Lymphatic metastasis1408
    No1305 (92.7)
    Yes103 (7.3)
TNM stage1408
    I1133 (80.5)
    II130 (9.2)
    III92 (6.5)
    IV53 (3.8)
Lymph vascular invasion1408
    No1347 (95.7)
    Yes61 (4.3)
CgA1408
    Negative1046 (74.3)
    Positive362 (25.7)
Syn1408
    Negative381 (27.1)
    Positive1027 (72.9)
Adjuvant therapy1408
    No1318 (93.6)
    Yes90 (6.4)